Last updated: March 27, 2024
Sponsor: European Institute of Oncology
Overall Status: Active - Recruiting
Phase
N/A
Condition
Bone Metastases
Neoplasms
Treatment
N/AClinical Study ID
NCT06335251
IEO 0728
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients treated with radiotherapy for curative, palliative, neo-adjuvant, andadjuvant purposes in the upper and lower limbs for: Primary bone tumors, Primary soft tissue tumors, Primary tumors of thecardio-circulatory system, Primary tumors of the lymphatic system, Primary tumors ofthe nervous system and skin, Secondary metastases from various origins localized inthat district.
- Signed informed consent
Exclusion
Exclusion Criteria:
- Radiotherapy in districts other than limbs.
Study Design
Total Participants: 3000
Study Start date:
February 22, 2018
Estimated Completion Date:
December 31, 2024
Study Description
Connect with a study center
European Institute of Oncology
Milan,
ItalyActive - Recruiting


Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.